North America Infectious Disease Diagnostics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - By Product (Kits & Reagents, Instruments, and Software & Services), Technology (Biosensor-Based, Immunodiagnostics, Molecular-Based Diagnostic Techniques, Clinical Biology, and Others), Application Type (Laboratory Testing and Point-of-Care Testing), Testing Type (Human Testing and Veterinary Testing), and End User (Diagnostic Laboratories, Hospitals & Clinics, Research Institutes, Homecare Settings, and Others)

No. of Pages: 115    |    Report Code: BMIRE00025326    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Infectious Disease Diagnostics Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Infectious Disease Diagnostics Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Infectious Disease Diagnostics Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Prevalence of infectious diseases
  • 5.1.2 Need for early and accurate diagnosis
5.2 Market Opportunities
  • 5.2.1 Government initiatives for disease control
  • 5.2.2 Expansion in remote testing services
5.3 Future Trends
  • 5.3.1 Point-of-care testing
  • 5.3.2 Molecular diagnostics advancements
5.4 Impact of Drivers and Restraints

6. North America Infectious Disease Diagnostics Market Regional Analysis

6.1 North America Infectious Disease Diagnostics Market Overview
6.2 North America Infectious Disease Diagnostics Market Revenue 2020-2030 (US$ Million)
6.3 North America Infectious Disease Diagnostics Market Forecast Analysis

7. North America Infectious Disease Diagnostics Market Analysis – by Product

7.1 Kits & Reagents
  • 7.1.1 Overview
  • 7.1.2 Kits & Reagents: North America Infectious Disease Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Instruments
  • 7.2.1 Overview
  • 7.2.2 Instruments: North America Infectious Disease Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Software & Services
  • 7.3.1 Overview
  • 7.3.2 Software & Services: North America Infectious Disease Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Infectious Disease Diagnostics Market Analysis – by Technology

8.1 Biosensor-Based
  • 8.1.1 Overview
  • 8.1.2 Biosensor-Based: North America Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Immunodiagnostics
  • 8.2.1 Overview
  • 8.2.2 Immunodiagnostics: North America Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Molecular-Based Diagnostic Techniques
  • 8.3.1 Overview
  • 8.3.2 Molecular-Based Diagnostic Techniques: North America Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Clinical Biology
  • 8.4.1 Overview
  • 8.4.2 Clinical Biology: North America Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9. North America Infectious Disease Diagnostics Market Analysis – by Application Type

9.1 Laboratory Testing and Point-of-Care Testing
  • 9.1.1 Overview
  • 9.1.2 Clinical Biology: North America Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10. North America Infectious Disease Diagnostics Market – North America Analysis

10.1 North America
  • 10.1.1 North America Infectious Disease Diagnostics Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.1.1.1 North America Infectious Disease Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.1.1 US: North America Infectious Disease Diagnostics Market Breakdown, by Product
    • 10.1.1.1.2 US: North America Infectious Disease Diagnostics Market Breakdown, by Technology
    • 10.1.1.1.3 US: North America Infectious Disease Diagnostics Market Breakdown, by Application Type
  • 10.1.1.2 Canada: North America Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.2.1 Canada: North America Infectious Disease Diagnostics Market Breakdown, by Product
    • 10.1.1.2.2 Canada: North America Infectious Disease Diagnostics Market Breakdown, by Technology
    • 10.1.1.2.3 Canada: North America Infectious Disease Diagnostics Market Breakdown, by Application Type
  • 10.1.1.3 Mexico : North America Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Infectious Disease Diagnostics Market Breakdown, by Product
    • 10.1.1.3.2 Mexico : North America Infectious Disease Diagnostics Market Breakdown, by Technology
    • 10.1.1.3.3 Mexico : North America Infectious Disease Diagnostics Market Breakdown, by Application Type

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Infectious Disease Diagnostics Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott Laboratories
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 ACON Laboratories Inc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Bio-Rad Laboratories Inc
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Bruker Corp
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Cardinal Health Inc
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Danaher Corp
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 DiaSorin SpA
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 F. Hoffmann-La Roche Ltd
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Trinity Biotech Plc
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - North America Infectious Disease Diagnostics Market

1. Abbott Laboratories 

2. ACON Laboratories Inc 

3. Bio-Rad Laboratories Inc 

4. Bruker Corp 

5. Cardinal Health Inc 

6. Danaher Corp 

7. DiaSorin SpA 

8. F. Hoffmann-La Roche Ltd 

9. Trinity Biotech Plc 

north-america-infectious-disease-diagnostics-market